Reuters logo
BRIEF-Zhejiang Shouxiangu Pharmaceutical unit receives GMP certificate
August 11, 2017 / 8:21 AM / a month ago

BRIEF-Zhejiang Shouxiangu Pharmaceutical unit receives GMP certificate

Aug 11(Reuters) - Zhejiang Shouxiangu Pharmaceutical Co Ltd

* Says its Jinhua-based wholly owned pharmaceutical unit received good manufacturing practice (GMP) certificate from Zhejiang Food and Drug Administration, on Aug. 10

* Certificate issued to tablets, granules and pills and the valid period is until July 31, 2022

Source text in Chinese: goo.gl/Yimfvq

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below